Nextage Therapeutics Ltd carries a market capitalization of 35.18M, placing it among publicly traded companies globally.
| Market Cap | 35.18M |
| Enterprise Value | N/A |
Nextage Therapeutics Ltd's stock has declined approximately -55.5783% over the past 52 weeks. The 50-day moving average sits at 31.41, while the 200-day moving average is 9.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | -55.5783% |
| 50-Day Moving Average | 31.41 |
| 200-Day Moving Average | 9.17 |
| Average Volume (20 Days) | N/A |
Nextage Therapeutics Ltd's most recent stock split took place on April 12, 2020 with a 20:1 split ratio.
| Last Split Date | 4/12/2020 |
| Split Ratio | 20:1 |